Real-world data supports Opdivo plus Yervoy efficacy for advanced renal cell carcinoma, mirroring clinical trial results.

Matthew R. Zibelman, MD, discusses treatment options in muscle-invasive, perioperative, and metastatic bladder cancer.

Despite concerns over cabozantinib's patent expiry, Exelixis projects robust future revenues, with lead pipeline candidate ...

NASCAR asks federal judge to dismiss teams' antitrust lawsuit (January 8, 2025, 6:31 PM ET) Helio Castroneves to attempt to qualify for Daytona 500 (January 6, 2025, 5:49 PM ET) ...